AS
Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ·Healthcare·Biotechnology
$5.99
-17.32%
Mkt Cap $4.29M
No analyst coverage available
We don't have analyst ratings or price target data for Aspire Biopharma Holdings, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.